Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Feb;139(2):181-5.
doi: 10.1007/s00432-012-1304-1. Epub 2012 Sep 9.

Biological characteristics of interval cancers: a role for biomarkers in the breast cancer screening

A Caldarella  1 , D Puliti, E Crocetti, S Bianchi, V Vezzosi, P Apicella, M Biancalani, A Giannini, C Urso, F Zolfanelli, E Paci
Affiliations

Biological characteristics of interval cancers: a role for biomarkers in the breast cancer screening

A Caldarella et al. J Cancer Res Clin Oncol. 2013 Feb.

Abstract

Introduction: In a population-based screening program, a percentage of tumors remain undetected; these tumors comprise a heterogeneous group, and they are more likely to have adverse prognostic features. The aim of this study was to identify differences in biological characteristics of screen-detected versus interval breast cancers in a population-based screening program according to molecular subtypes.

Materials and methods: We analyzed the population-based data from a long-running screening program in the area of Florence. Data on screening history and on age, T and N status, grade, histotype, hormonal status and Ki-67 and HER2 expression were retrieved. Subtypes of breast cancer were defined on the expression of ER, PR, Ki-67 and HER2: luminal A if ER/PR+, HER2- and Ki67 <14 %, luminal B (HER2 negative) if ER/PR+, HER2- and Ki67 ≥14 %, luminal B (HER2 positive) if ER/PR+ and HER2+, triple negative if ER/PR-and HER2-, HER2 positive if ER/PR- and HER2+. Association between molecular subtypes and mode of detection will be evaluated by a logistic regression model adjusted for the potential confounding variables.

Results: Information about biomarkers was known for 277 cases, 211 screening-detected and 66 interval cancers. Among interval cases, the triple-negative cancers were more represented than luminal A (OR = 3.52; CI, 1.112-11.13; p = 0.0319), while the proportion of HER2+ was quite similar (OR = 1.57; p = 0.4709).

Conclusion: Although made on a small number of cases, our results suggest a difference in distribution of molecular subtypes according to mode detection, confirming the results of earlier studies.

PubMed Disclaimer

References

    1. Anttinen J, Kuopio T, Nykanen M, Torkkeli H, Saari U, Juhola M (2003) Her-2/Neu oncogene amplification and protein over-expression in interval and screen-detected breast cancers. Anticancer Res 23(5b):4213–4218 - PubMed
    1. Bernstein L, Lacey JV Jr (2011) Receptors, associations, and risk factor differences by breast cancer subtypes: positive or negative? JNCI 103(6):2–4 - PubMed
    1. Caldarella A, Crocetti E, Bianchi S, Vezzosi V, Urso C, Biancalani M, Zappa M (2011) Female breast cancer status according to ER, PR and HER2 expression: a population based analysis. Pathol Oncol Res 17(3):753–758 - PubMed
    1. Collett K, Stefansonn IM, Eide J, Braaten A, Wang H, Eide GE, Thoresen SO, Foulkes WD, Akslen LA (2005) A basal epithelial phenotype is more frequent in interval breast cancer compared with screen detected tumors. Cancer Epidemiol Biomarkers Prev 14(5):1108–1112 - PubMed
    1. Conroy SM, Pagano I, Kolonel LN, Maskarinec G (2011) Mammographic density and hormone receptor expression in breast cancer: the multiethnic cohort study. Cancer Epidemiol 35(5):448–452 - PMC - PubMed